Global Markets for Vascular Closure Devices
Published January 2015 | 105 Pages | 53 Exhibits | Forecasts Through 2019
Request Info
Order individually or subscribe and get a complete intel platform.
Overview
The global market for vascular closure devices (VCDs), which are often used following arterial puncture for cardiac catheterizations and other procedures, was valued at $706 million in 2013. As analyzed in a new report by Life Science Intelligence, the use of these devices, which include implantables as well as external compression products, will be strongly influenced by regional and global trends toward the implementation of cost-effective care as well as the rising use of transradial access-factors which are expected to restrain growth in the market for VCDs at the high end of the price range. This report analyzes and quantifies the key forces driving the global market for VCDs in the U.S., Europe, Asia-Pacific and the rest of the world for the period 2012-2019; some of the major issues covered in the report include:
• Trends in arterial access as well as the use of manual compression for site closure;
• Competitive factors and product introductions;
• Procedure volumes;
• Critical infrastructure and market metrics; and
• Quantitative factors including units, pricing, and product sales.
Companies Covered
Abbott VascularAccessClosure (Cardinal Health)
Advanced Vascular Dynamics
Benrikal Services
Cardiva Medical
Cordis Corporation (Johnson & Johnson)
Marine Polymer Technologies
Morris Innovative
Scion BioMedical
St. Jude Medical
Terumo
TZ Medical
Vascular Solutions
Table of Contents
1. EXECUTIVE SUMMARY 1.1 Methods of Vascular Closure: VCDs and Manual Compression 1.2 The Global Market by Product Type 1.3 The Global Market by Region 1.4 Competitive Analysis Exhibit 1-1: Global Vascular Closure Procedures by Type, 2012-2019 Exhibit 1-2: The Global Market Forecast for Vascular Closure Devices by Type from 2012-2019 Exhibit 1-3: The Global Market Forecast for Vascular Closure Devices by Region from 2012-2019 Exhibit 1-4: Global Supplier Shares in 2012 and 2013 2. OVERVIEW 2.1 The Circulatory System 2.2 Vascular Anatomy and Physiology 2.2.1 Peripheral Arteries 2.2.2 Coronary Arteries 2.2.3 Arteries of the Head and Neck 2.3 Vessel Tissues and Structures 2.4 The Wound Healing Process 2.4.1 The Inflammatory Phase 2.4.2 Proliferative Phase 2.4.3 Remodeling Phase 2.4.4 Factors Affecting Vascular Closure 2.5 Conditions Necessitating Vascular Access 2.6 Procedural Economics 2.6.1 Reimbursement 2.6.1.1 Revenue Codes 2.6.1.2 DRG Codes 2.6.1.3 Economic Justification for Vascular Closure Technologies Exhibit 2-1: Overview of the Circulatory System Exhibit 2-2: Major Arteries in the Cardiovascular System Exhibit 2-3: Types and Functions of the Blood Vessels Exhibit 2-4: Peripheral Arteries and Arteries of the Lower Extremity Exhibit 2-5: Arteries of the Hand, Including the Radial Artery Exhibit 2-6: Arteries of the Head and Neck Exhibit 2-7: Anatomy of the Arteries and Veins Exhibit 2-8: The Process of Healing Vessel Wounds Exhibit 2-9: Cardiovascular Pathologies Necessitating Vascular Access Exhibit 2-10: Average Medicare Reimbursements in 2014 for Common Catheterization Procedures 3. VASCULAR CLOSURE METHODS AND DEVICES 3.1 Manual Compression 3.2 Vascular Closure Devices 3.2.1 Implantable Devices 3.2.2 External Compression Products 3.2.3 Companies and Products Exhibit 3-1: Methods of Vascular Closure Exhibit 3-2: Types of Vascular Closure Devices Exhibit 3-3: Clinical Studies Examining Vascular Closure Devices Exhibit 3-4: Selected Vascular Closure Devices in 2014 Exhibit 3-5: Abbott Vascular's Vascular Closure Devices Exhibit 3-6: AccessClosure's Mynx Ace Vascular Closure Device Exhibit 3-7: Advanced Vascular Dynamics, Selected Vascular Closure Devices Exhibit 3-8: Cardiva Medical's Catalyst III Exhibit 3-9: Cordis's EXOSEAL Vascular Closure Device Exhibit 3-10: Morris Innovative's FISH Device – Procedural Description Exhibit 3-11: St. Jude Medical's Angio-Seal STS Plus and VIP Vascular Closure Devices Exhibit 3-12: Scion BioMedical's Clo-Sur PLUS P.A.D. Exhibit 3-13: Terumo's TR Band Exhibit 3-14: TZ Medical's Neptune and Neptune Plus Exhibit 3-15: Vascular Solutions' D-Stat 4. PROCEDURE FORECASTS AND MARKET ANALYSIS 4.1 The Global Market Forecast for Vascular Closure Devices 4.2 The Market by Region 4.2.1 The United States 4.2.2 Europe 4.2.3 Asia-Pacific and the Rest-of-the-World 4.2.4 Global Supplier Shares Exhibit 4-1: Global Vascular Closure Procedures by Type, 2012-2019 Exhibit 4-2: The Global Market Forecast for Vascular Closure Devices from 2012-2019 Exhibit 4-3: The Global Market Forecast for Vascular Closure Devices by Type from 2012-2019 Exhibit 4-4: The Global Market Forecast for Vascular Closure Devices by Method of Access from 2012-2019 Exhibit 4-5: The Global Market Forecast for Vascular Closure Devices by Region from 2012-2019 Exhibit 4-6: U.S. Cardiac Catheterization Procedures by Arterial Access, 2012-2019 Exhibit 4-7: Cardiac Catheterizations by Type in the U.S., 2012-2019 Exhibit 4-8: Vascular Closure Procedures by Type in the U.S., 2012-2019 Exhibit 4-9: The U.S. Market Forecast for Vascular Closure Devices from 2012-2019 Exhibit 4-10: The U.S. Market Forecast for Vascular Closure Devices by Type from 2012-2019 Exhibit 4-11: The U.S. Market Forecast for Vascular Closure Devices by Method of Access from 2012-2019 Exhibit 4-12: European Cardiac Catheterization Procedures by Arterial Access, 2012-2019 Exhibit 4-13: Cardiac Catheterizations by Type in Europe, 2012-2019 Exhibit 4-14: Vascular Closure Procedures by Type in Europe, 2012-2019 Exhibit 4-15: The Market Forecast for Vascular Closure Devices in Europe from 2012-2019 Exhibit 4-16: The Market Forecast for Vascular Closure Devices in Europe by Type from 2012-2019 Exhibit 4-17: The European Market Forecast for Vascular Closure Devices by Method of Access from 2012-2019 Exhibit 4-18: AP & ROW Cardiac Catheterization Procedures by Arterial Access, 2012-2019 Exhibit 4-19: AP & ROW Cardiac Catheterizations by Type, 2012-2019 Exhibit 4-20: AP & ROW Vascular Closure Procedures by Type, 2012-2019 Exhibit 4-21: AP & ROW Market Forecast for Vascular Closure Devices from 2012-2019 Exhibit 4-22: AP & ROW Market Forecast for Vascular Closure Devices by Type from 2012-2019 Exhibit 4-23: The Market Forecast for Vascular Closure Devices by Method of Access in AP & ROW Countries from 2012-2019 Exhibit 4-24: Global Supplier Shares in 2012 and 2013 5. COMPANY PROFILES 5.1 Abbott Vascular 5.2 AccessClosure (Cardinal Health) 5.3 Advanced Vascular Dynamics 5.4 Benrikal Services 5.5 Cardiva Medical 5.6 Cordis Corporation (Johnson & Johnson) 5.7 Marine Polymer Technologies 5.8 Morris Innovative 5.9 Scion BioMedical 5.10 St. Jude Medical 5.11 Terumo 5.12 TZ Medical 5.13 Vascular Solutions
Ready to get started?
We help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.
